JP2006500002A5 - - Google Patents

Download PDF

Info

Publication number
JP2006500002A5
JP2006500002A5 JP2003548687A JP2003548687A JP2006500002A5 JP 2006500002 A5 JP2006500002 A5 JP 2006500002A5 JP 2003548687 A JP2003548687 A JP 2003548687A JP 2003548687 A JP2003548687 A JP 2003548687A JP 2006500002 A5 JP2006500002 A5 JP 2006500002A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
level
individual
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003548687A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006500002A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/038556 external-priority patent/WO2003047421A2/en
Publication of JP2006500002A publication Critical patent/JP2006500002A/ja
Publication of JP2006500002A5 publication Critical patent/JP2006500002A5/ja
Pending legal-status Critical Current

Links

JP2003548687A 2001-12-03 2002-12-02 糖尿病の診断および治療のための方法および試薬 Pending JP2006500002A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33663301P 2001-12-03 2001-12-03
PCT/US2002/038556 WO2003047421A2 (en) 2001-12-03 2002-12-02 Methods and reagents for diagnosis and treatment of diabetes

Publications (2)

Publication Number Publication Date
JP2006500002A JP2006500002A (ja) 2006-01-05
JP2006500002A5 true JP2006500002A5 (https=) 2006-02-16

Family

ID=23316971

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003548687A Pending JP2006500002A (ja) 2001-12-03 2002-12-02 糖尿病の診断および治療のための方法および試薬

Country Status (6)

Country Link
US (2) US7144985B2 (https=)
EP (1) EP1461351A4 (https=)
JP (1) JP2006500002A (https=)
AU (1) AU2002351214B2 (https=)
CA (1) CA2468991A1 (https=)
WO (1) WO2003047421A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7054758B2 (en) 2001-01-30 2006-05-30 Sciona Limited Computer-assisted means for assessing lifestyle risk factors
US6812210B2 (en) * 2001-03-15 2004-11-02 Research Development Foundation Urocortin-III and uses thereof
KR101666228B1 (ko) 2007-09-28 2016-10-13 인트렉손 코포레이션 생물치료학적 분자를 발현시키기 위한 치료학적 유전자-스위치 작제물 및 생물반응기, 및 이의 용도
SG171957A1 (en) * 2008-11-04 2011-07-28 Janssen Pharmaceutica Nv Crhr2 peptide agonists and uses thereof
EP2584041A1 (en) * 2011-10-21 2013-04-24 Industrial Cooperation Foundation Chonbuk National University Composition for preventing or treating diabetes comprising nad glycohydrolase inhibitor as active ingredient

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020082409A1 (en) 2000-10-26 2002-06-27 Hsu Sheau Yu Stresscopins and their uses
US6812210B2 (en) 2001-03-15 2004-11-02 Research Development Foundation Urocortin-III and uses thereof

Similar Documents

Publication Publication Date Title
Lund et al. Pancreatic preproglucagon cDNA contains two glucagon-related coding sequences arranged in tandem.
Otsuka et al. Identification of essential amino acid residues of the NorM Na+/multidrug antiporter in Vibrio parahaemolyticus
US9562088B2 (en) Pegylated CD154 peptides and methods of inhibiting CD40 interacations with CD154
DE777732T1 (de) Modulatoren von dem körpergewicht, entsprechende nukleinsaüre und proteine, und diagnostische und therapeutische anwendungen davon
CA2336218A1 (en) Neurotrophic factors
JPH04503808A (ja) 新規インシュリン化合物
JP2014523871A5 (https=)
JP2006502702A5 (https=)
JP2006500002A5 (https=)
CN111925419B (zh) 一种多肽作为嗅觉受体Olfr109拮抗剂配体的应用
JP2005528921A5 (https=)
Wang et al. Distinct domains of IFNα mediate immune and analgesic effects respectively
JP2002515223A5 (https=)
JP2009516155A5 (https=)
JP2005519590A5 (https=)
JP2005529603A5 (https=)
KR102659639B1 (ko) 유전자 마커를 이용한 설폰요소제 의존성 예측용 조성물 및 그 예측 방법
CN1962695B (zh) 类胰高血素肽-1融合蛋白及其制备和用途
JP2004533841A5 (https=)
CA2385266A1 (en) Novel cell cycle checkpoint genes and proteins encoded thereby
RU2005110955A (ru) Применение erg4-мутантов saccharomyces cerevisiae для экспрессии переносчиков глюкозы млекопитающих
CA2473566A1 (en) Pim-3 kinase as a target for type 2 diabetes mellitus
CN121494938A (zh) Glp1r激活多肽或其药学上可接受的盐及其用途
CN121494929A (zh) Glp1r激活多肽或其药学上可接受的盐及其用途
CN118666959A (zh) 一种二肽基肽酶ⅳ抑制六肽及其用途